Your search for major depressive disorder returned 306 results

Researchers examined how the associations of life event stress with impulsivity, anxiety, and depressed mood change in the presence of sleep disturbance.

A study of Chinese healthcare workers may foreshadow the mental health burden placed upon physicians, nurses, and other professionals as COVID-19 strains the medical system in the United States.

The influence of gut microbiota extends to the brain via neuroinflammation, resulting in symptoms associated with major depressive disorder.

Depression contributed to elevated ratings in patients with MDD on items related to perceived inability to cope with the negative consequences of disturbed sleep and reported tendency to cancel social plans after poor sleep.

Patients with psychotic depression who experienced an illness relapse while receiving placebo also had a decline in cortical thickness, emphasizing the essential role antipsychotics play in treating disorders where psychosis is present.

Overall, in all patients with MDD, sleep ultradian cycle number was positively associated with REMS percentage, REMS duration, and REMS/NREMS ratio and negatively associated with REM latency.

The stresses and sleep disturbances of shift work can lead to major mental health issues, as well as workplace challenges, including safety concerns and poor on-the-job performance.

After controlling for depression, irritability, and anxiety, the investigators found no direct effect of ADHD symptoms on suicidality.

The study provides strong evidence for the utility of resting-state fMRI measures in predicting the development of attentional or mood disorders in children.

In boys but not girls, reduced sleep duration at age 8 and 10 years predicted the development of behavioral disorder symptoms 2 years later.

Researchers sought to address the possible link between cognitive or mood symptoms and statins.

Anna S. Urrila, MD and colleagues sought to explore whether sleep symptoms in adolescents with MDD were associated with long-term outcomes.

The Food and Drug Administration (FDA) has granted Fast Track designation to an investigational intranasal formulation of racemic ketamine for the potential treatment of acute suicidal ideation and behavior in patients with major depressive disorder.

Researchers found evidence for a divergent association between lifetime MDD and the prevalence and severity of symptoms in patients with migraine.

The presence of psychiatric disorders in patients with idiopathic intracranial hypertension is associated with poor treatment outcomes.

The risk for early incident transient ischemic attack and ischemic stroke is significantly higher in young adults with posttraumatic stress disorder.

In a clinical practice guideline, updated recommendations are presented for the evaluation and management of attention-deficit/hyperactivity disorder (ADHD) in children.

Some nutrient supplements may be beneficial as adjunctive treatment for common mental health condition.

The risk factors for tardive dyskinesia in patients taking antipsychotics include age, comorbid diagnoses, and high medication dosages.

Older patients who develop delirium after surgery are more likely to show signs of cognitive dysfunction one month later.

A number of psychiatric and neurodegenerative diseases are associated with abnormal imaging findings, which can help psychiatrists reach a diagnosis.

Migraine with active headache may predict other painful physical symptoms in patients with major depressive disorder.

Cyclic vomiting syndrome (CVS) and benign paroxysmal torticollis (BPT) during infancy are associated with a high risk for developing headache later in life.

Findings suggest VNS to be effective in the treatment of epilepsy and comorbid depression.

Risk of autism spectrum disorder with and without intellectual disability increases with prenatal and infant exposure to several common ambient pesticides.

Investigators analyzed the clinical, psychological, and cognitive factors that affect perceived and cognitive performance fatigability in patients with multiple sclerosis.

Polyneuropathies occurring in multiple sclerosis contribute to neurological disability.

Researchers suggest that improvement in cognitive function should be a goal for major depressive disorder because their data showed little improvement in the cognitive abilities of patients with major depression after treatment with psychological interventions.

Aerobic exercise may be associated with a reduction in the number of migraine days.

The tryptophan-kynurenine-NAD+ (TK) pathway may provide accurate cerebrospinal fluid biomarkers.